rs12632942

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006514.4(SCN10A):​c.3275T>C​(p.Leu1092Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.247 in 1,611,844 control chromosomes in the GnomAD database, including 51,330 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 4103 hom., cov: 33)
Exomes 𝑓: 0.25 ( 47227 hom. )

Consequence

SCN10A
NM_006514.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.776

Publications

58 publications found
Variant links:
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
SCN10A Gene-Disease associations (from GenCC):
  • sodium channelopathy-related small fiber neuropathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • episodic pain syndrome, familial, 2
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • Brugada syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
  • Brugada syndrome 1
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020908415).
BP6
Variant 3-38723507-A-G is Benign according to our data. Variant chr3-38723507-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259997.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN10ANM_006514.4 linkc.3275T>C p.Leu1092Pro missense_variant Exon 19 of 28 ENST00000449082.3 NP_006505.4 Q9Y5Y9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN10AENST00000449082.3 linkc.3275T>C p.Leu1092Pro missense_variant Exon 19 of 28 1 NM_006514.4 ENSP00000390600.2 Q9Y5Y9
SCN10AENST00000643924.1 linkc.3272T>C p.Leu1091Pro missense_variant Exon 18 of 27 ENSP00000495595.1 A0A2R8Y6J6
SCN10AENST00000655275.1 linkc.3299T>C p.Leu1100Pro missense_variant Exon 19 of 28 ENSP00000499510.1 A0A590UJM0

Frequencies

GnomAD3 genomes
AF:
0.221
AC:
33587
AN:
152066
Hom.:
4103
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.138
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.149
Gnomad ASJ
AF:
0.341
Gnomad EAS
AF:
0.403
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.273
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.256
Gnomad OTH
AF:
0.216
GnomAD2 exomes
AF:
0.240
AC:
58530
AN:
243924
AF XY:
0.245
show subpopulations
Gnomad AFR exome
AF:
0.133
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.335
Gnomad EAS exome
AF:
0.389
Gnomad FIN exome
AF:
0.271
Gnomad NFE exome
AF:
0.259
Gnomad OTH exome
AF:
0.243
GnomAD4 exome
AF:
0.250
AC:
364980
AN:
1459660
Hom.:
47227
Cov.:
34
AF XY:
0.250
AC XY:
181556
AN XY:
725990
show subpopulations
African (AFR)
AF:
0.130
AC:
4341
AN:
33460
American (AMR)
AF:
0.121
AC:
5363
AN:
44454
Ashkenazi Jewish (ASJ)
AF:
0.332
AC:
8663
AN:
26108
East Asian (EAS)
AF:
0.437
AC:
17309
AN:
39632
South Asian (SAS)
AF:
0.233
AC:
20050
AN:
85976
European-Finnish (FIN)
AF:
0.273
AC:
14535
AN:
53312
Middle Eastern (MID)
AF:
0.229
AC:
1318
AN:
5766
European-Non Finnish (NFE)
AF:
0.251
AC:
278670
AN:
1110636
Other (OTH)
AF:
0.244
AC:
14731
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
13815
27630
41444
55259
69074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9418
18836
28254
37672
47090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.221
AC:
33596
AN:
152184
Hom.:
4103
Cov.:
33
AF XY:
0.223
AC XY:
16583
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.138
AC:
5737
AN:
41540
American (AMR)
AF:
0.149
AC:
2279
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.341
AC:
1183
AN:
3470
East Asian (EAS)
AF:
0.403
AC:
2085
AN:
5168
South Asian (SAS)
AF:
0.241
AC:
1159
AN:
4816
European-Finnish (FIN)
AF:
0.273
AC:
2894
AN:
10596
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.256
AC:
17404
AN:
67978
Other (OTH)
AF:
0.214
AC:
452
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1368
2735
4103
5470
6838
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
366
732
1098
1464
1830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.245
Hom.:
22171
Bravo
AF:
0.209
TwinsUK
AF:
0.250
AC:
926
ALSPAC
AF:
0.241
AC:
928
ESP6500AA
AF:
0.142
AC:
625
ESP6500EA
AF:
0.260
AC:
2236
ExAC
AF:
0.241
AC:
29298
Asia WGS
AF:
0.272
AC:
946
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 09, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 23, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Jun 10, 2016
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Brugada syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Episodic pain syndrome, familial, 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cardiovascular phenotype Benign:1
Dec 21, 2018
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.046
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
11
DANN
Benign
0.84
DEOGEN2
Benign
0.036
T;.;T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0069
N
LIST_S2
Benign
0.24
.;T;T;T
MetaRNN
Benign
0.0021
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.72
N;.;N;.
PhyloP100
-0.78
PrimateAI
Benign
0.30
T
PROVEAN
Benign
3.2
N;.;.;.
REVEL
Benign
0.18
Sift
Benign
0.60
T;.;.;.
Sift4G
Benign
0.41
T;.;.;.
Polyphen
0.0
B;.;B;.
Vest4
0.013
MPC
0.092
ClinPred
0.0018
T
GERP RS
-0.53
Varity_R
0.087
gMVP
0.40
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12632942; hg19: chr3-38764998; COSMIC: COSV71861243; API